???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Herlander Marques

Nomes de citação

  • Marques, Herlander

Identificadores de autor

Ciência ID
841F-AA5B-2791
ORCID iD
0000-0002-5854-4444
Produções

Publicações

Artigo em revista
  1. Mara Fernandes; Herlander Marques; Ana L Teixeira; r medeiros. "miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine". Cancers (2021): https://www.mdpi.com/2072-6694/13/24/6324.
    10.3390/cancers13246324
  2. Mara Fernandes; Herlander Marques; Ana L Teixeira; r medeiros. "Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives". Biomedicines (2021): https://www.mdpi.com/2227-9059/9/12/1934.
    10.3390/biomedicines9121934
  3. Oliveira, Alexandra; Silva, Eliana; Aguiar, Joyce Cristina Santos; Faria, Mónica Brígida; Reis, L. P.; Cardoso, Henrique; Gonçalves, Joaquim; et al. "Biometrics and quality of life of lymphoma patients: A longitudinal mixed-model approach". (2021): http://hdl.handle.net/1822/68055.
    10.1111/exsy.12640
  4. Santos, Alexandra; Oliveira, Ana; Raimundo, Ana; Coelho, Andreia; Monteiro, Andreia; Araújo, António; Moreira, António; et al. "Patient Blood Management – is its application possible in oncology?". (2021): https://rponcologia.com/index.php/rpo/article/view/21.
  5. Oliveira, Alexandra; Silva, Eliana; Aguiar, Joyce; Faria, Brigida Monica; Reis, Luís Paulo; Cardoso, Henrique; Gonçalves, Joaquim; Sá, Jorge Oliveira e Carvalho; Victor, Marques Herlander. "Biometrics and quality of life of lymphoma patients: A longitudinal mixed-model approach". (2020): http://hdl.handle.net/10400.22/16524.
    10.1111/exsy.12640
  6. Afonso, Julieta; Pinto, Tatiana; Simoes-Sousa, Susana; Schmitt, Fernando; Longatto-Filho, Adhemar [UNESP]; Pinheiro, Celine; Marques, Herlander; Baltazar, Fatima. "Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma-MCT1 as potential target in diffuse large B cell lymphoma". (2019): http://hdl.handle.net/11449/184505.
    http://dx.doi.org/10.1007/s13402-019-00426-2
  7. Afonso, Julieta Alexandra Pereira; Pinto, Tatiana; Sousa, Susana Patrícia Simões; Schmitt, Fernando; Longatto, Adhemar; Pinheiro, Céline; Marques, Herlander; Baltazar, Fátima. "Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma". (2019): http://hdl.handle.net/1822/62454.
    10.1007/s13402-019-00426-2
  8. Eira,Isabel M.; Correia,Sandra I.; Ângela,Cristina; Marques,Herlander. "T-Cell Large Granular Lymphocyte Leukemia: The Experience of a Single Center". (2018): http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-671X2018000100007.
  9. Macauda, Angelica; Castelli, Eleonora; Buda, Gabriele; Pelosini, Matteo; Butrym, Aleksandra; Watek, Marzena; Kruszewski, Marcin; et al. "Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients". (2018): http://hdl.handle.net/1822/58469.
    10.1111/bjh.15521
  10. Macauda, A.; Calvetti, D.; Maccari, G.; Hemminki, K.; Försti, A.; Goldschmidt, H.; Weinhold, N.; et al. "Identification of miRSNPs associated with the risk of multiple myeloma". International Journal of Cancer 140 3 (2017): 526-534. http://www.scopus.com/inward/record.url?eid=2-s2.0-85001777482&partnerID=MN8TOARS.
    10.1002/ijc.30465
  11. Macauda, Angelica; Calvetti, Diego; Maccari, Giuseppe; Hemminki, Kari; Försti, Asta; Goldschmidt, Hartmut; Weinhold, Niels; et al. "Identification of miRSNPs associated with the risk of multiple myeloma". (2017): http://hdl.handle.net/1822/50171.
    10.1002/ijc.30465
  12. Cárcano, F.M.; Vidal, D.O.; van Helvoort Lengert, A.; Neto, C.S.; Queiroz, L.; Marques, H.; Baltazar, F.; et al. "Hotspot TERT promoter mutations are rare events in testicular germ cell tumors". Tumor Biology 37 4 (2016): 4901-4907. http://www.scopus.com/inward/record.url?eid=2-s2.0-84946130447&partnerID=MN8TOARS.
    10.1007/s13277-015-4317-y
  13. Ríos-Tamayo, R.; Lupiañez, C.B.; Campa, D.; Hielscher, T.; Weinhold, N.; Martínez-López, J.; Jerez, A.; et al. "A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis". Oncotarget 7 37 (2016): 59029-59048. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991289594&partnerID=MN8TOARS.
    10.18632/oncotarget.10665
  14. Marques, H.; Freitas, J.; Medeiros, R.; Longatto-Filho, A.. "Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability". International Journal of Molecular Epidemiology and Genetics 7 3 (2016): 126-136. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991649502&partnerID=MN8TOARS.
  15. Cárcano, F.M.; Lengert, A.H.; Vidal, D.O.; Scapulatempo Neto, C.; Queiroz, L.; Marques, H.; Baltazar, F.; et al. "Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors". Andrology 4 5 (2016): 866-872. http://www.scopus.com/inward/record.url?eid=2-s2.0-84982152496&partnerID=MN8TOARS.
    10.1111/andr.12200
  16. Martins, S.F.; Amorim, R.; Viana-Pereira, M.; Pinheiro, C.; Costa, R.F.A.; Silva, P.; Couto, C.; et al. "Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis". BMC Cancer 16 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84979211096&partnerID=MN8TOARS.
    10.1186/s12885-016-2566-9
  17. Marques, Herlander; Freitas, J.; Medeiros, Rui; Longatto Filho, Adhemar. "Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability". (2016): http://hdl.handle.net/1822/45076.
  18. Carvalho, Susana; Gomes, Marília; Marques, Herlander; Pereira, Catarina; Rubio-Rodríguez, Darío; Rubio-Terrés, Carlos; Sottomayor, Carlos. "Cost-effectiveness Analysis of Rituximab Maintenance Treatment in Patients With Follicular Lymphoma who Respond to First Line Induction Therapy in Portugal". (2016): http://revista.farmacoterapia.pt/index.php/rpf/article/view/90.
    10.25756/rpf.v8i1.90
  19. Ríos-Tamayo, Rafael; Lupiañez, Carmen Belén; Campa, Daniele; Hielscher, Thomas; Weinhold, Niels; Martínez-López, Joaquin; Jerez, Andrés; et al. "A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis". (2016): http://hdl.handle.net/1822/45370.
    10.18632/oncotarget.10665
  20. Cárcano, Flavio Mavignier; Vidal, Daniel Onofre; Lengert, André van Helvoort; Scapulatempo-Neto, Cristovam; Queiroz, Luisa; Marques, Herlander; Baltazar, Fátima; et al. "Hotspot TERT promoter mutations are rare events in testicular germ cell tumors". (2016): http://hdl.handle.net/1822/45053.
    10.1007/s13277-015-4317-y
  21. Campa D; Martino A; Varkonyi J; Lesueur F; Jamroziak K; Landi S; Jurczyszyn A; et al. "Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.". (2015): http://europepmc.org/abstract/med/25066524.
    10.1002/ijc.29101
  22. Ziv, E.; Dean, E.; Hu, D.; Martino, A.; Serie, D.; Curtin, K.; Campa, D.; et al. "Erratum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients (Nature Communications (2015) 6 (7539) DOI: 10.1038/ncomms8539)". Nature Communications 6 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84949566996&partnerID=MN8TOARS.
    10.1038/ncomms10203
  23. Ríos, R.; Lupiañez, C.B.; Campa, D.; Martino, A.; Martínez-López, J.; Martínez-Bueno, M.; Varkonyi, J.; et al. "Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium". Endocrine-Related Cancer 22 4 (2015): 545-559. http://www.scopus.com/inward/record.url?eid=2-s2.0-84940102184&partnerID=MN8TOARS.
    10.1530/ERC-15-0029
  24. Ziv E; Dean E; Hu D; Martino A; Serie D; Curtin K; Campa D; et al. "Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.". (2015): http://europepmc.org/abstract/med/26198393.
    10.1038/ncomms8539
  25. Ziv, Elad; Dean, Eric; Hu, Donglei; Martino, Alessandro; Serie, Daniel; Curtin, Karen; Campa, Daniele; et al. "Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients". (2015): http://hdl.handle.net/1822/62280.
    10.1038/ncomms8539
  26. Campa, Daniele; Martino, Alessandro; Varkonyi, Judit; Lesueur, Fabienne; Jamroziak, Krzysztof; Landi, Stefano; Jurczyszyn, Artur; et al. "Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length". (2015): http://hdl.handle.net/1822/40203.
    10.1002/ijc.29101
  27. Ríos, Rafael; Lupiañez, Carmen Belén; Campa, Daniele; Martino, Alessandro; Martínez-López, Joaquin; Martínez-Bueno, Manuel; Varkonyi, Judit; et al. "Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium". (2015): http://hdl.handle.net/1822/40536.
    10.1530/ERC-15-0029
  28. Martino A; Campa D; Jurczyszyn A; Martínez-López J; Moreno MJ; Varkonyi J; Dumontet C; et al. "Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.". (2014): http://europepmc.org/abstract/med/24521996.
    10.1158/1055-9965.EPI-13-1115
  29. Martino, Alessandro; Campa, Daniele; Jurczyszyn, Artur; Martínez-Lopez, Joaquín; Moreno, Maria José; Varkonyi, Judit; Dumontet, Charles; et al. "Genetic variants and multiple myeloma risk : IMMEnSE validation of the best reported associations : an extensive replication of the associations from the Candidate gene era". (2014): http://hdl.handle.net/1822/33452.
    10.1158/1055-9965.EPI-13-1115
  30. Martino, A.; Campa, D.; Buda, G.; Sainz, J.; García-Sanz, R.; Jamroziak, K.; Reis, R.M.; et al. "Erratum: Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: A case - Control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium (Leukemia (2012) 26 (1419-1422) DOI: 10.1038/leu.2011.352)". Leukemia 27 7 (2013): 1615-1616. http://www.scopus.com/inward/record.url?eid=2-s2.0-84880310077&partnerID=MN8TOARS.
    10.1038/leu.2013.146
  31. Martino, A.; Sainz, J.; Reis, R.M.; Moreno, V.; Buda, G.; Lesueur, F.; Marques, H.; et al. "Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: A case-control study in the context of the IMMEnSE consortium". Journal of Human Genetics 58 3 (2013): 155-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875457423&partnerID=MN8TOARS.
    10.1038/jhg.2012.149
  32. Martino, Alessandro; Sainz, Juan; Reis, R. M.; Moreno, Victor; Buda, Gabriele; Lesueur, Fabienne; Marques, Herlander; et al. "Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk : a case-control study in the context of IMMEnSE consortium". (2013): http://hdl.handle.net/1822/33626.
    10.1038/jhg.2012.149
  33. Marques H; Catarino R; Domingues N; Barros E; Portela C; Almeida MI; Costa S; et al. "Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis.". (2012): http://europepmc.org/abstract/med/23226803.
    10.3892/ol.2012.913
  34. Martino A; Campa D; Jamroziak K; Reis RM; Sainz J; Buda G; García-Sanz R; et al. "Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.". (2012): http://europepmc.org/abstract/med/22823248.
    10.1111/j.1365-2141.2012.09244.x
  35. Martino A; Campa D; Buda G; Sainz J; García-Sanz R; Jamroziak K; Reis RM; et al. "Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.". (2012): http://europepmc.org/abstract/med/22182917.
    10.1038/leu.2011.352
  36. Campa D; Martino A; Sainz J; Buda G; Jamroziak K; Weinhold N; Vieira Reis RM; et al. "Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.". (2012): http://europepmc.org/abstract/med/22590720.
    10.1111/j.1365-2141.2012.09047.x
  37. Martino A; Sainz J; Buda G; Jamroziak K; Reis RM; García-Sanz R; Jurado M; et al. "Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).". (2012): http://europepmc.org/abstract/med/22159523.
    10.3892/ijo.2011.1284
  38. Carvalho A; Cunha C; Almeida AJ; Osório NS; Saraiva M; Teixeira-Coelho M; Pedreiro S; et al. "The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma.". (2012): http://europepmc.org/abstract/med/21866115.
    10.1038/gene.2011.59
  39. Martino, Alessandro; Sainz, Juan; Buda, Gabriele; Jamroziak, Krzysztof; Reis, R. M.; García-Sanz, Ramón; Jurado, Manuel; et al. "Genetics and molecular epidemiology of multiple myeloma : the rationale for the IMMEnSE consortium (review)". (2012): http://hdl.handle.net/1822/29136.
    10.3892/ijo.2011.1284
  40. Reis, R. M.; Campa, Danielr; Martino, Alessandro; Sainz, Juan; Buda, Gabriele; Jamroziak, Krzysztof; Weinhold, Niels; et al. "Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium". (2012): http://hdl.handle.net/1822/33602.
    10.1111/j.1365-2141.2012.09047.x
  41. Carvalho, Agostinho; Cunha, Cristina; Almeida, A. J.; Osório, Nuno S.; Saraiva, Margarida; Coelho, Maria Teixeira; Pedreiro, Susana; et al. "The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma". (2012): http://hdl.handle.net/1822/23858.
    10.1038/gene.2011.59
  42. Marques, Herlander; Catarino, Raquel; Domingues, Nelson; Barros, Eliane; Portela, Catarina; Almeida, Maria Inês; Costa, Sandra; et al. "Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non Hodgkin's lymphoma is not associated with prognosis". (2012): http://hdl.handle.net/1822/23822.
    10.3892/ol.2012.913
  43. Rocha J; Luz Duarte M; Marques H; Torres F; Tavares P; Silva A; Brito C. "Association of adult mastocytosis with M541L in the transmembrane domain of KIT.". (2010): http://europepmc.org/abstract/med/20236206.
    10.1111/j.1468-3083.2010.03599.x
  44. Queiroz, L.; Sousa, F.; Marques, H.. "Influence of socio-demographic and clinical factors in health related quality of Life of hemato-oncologic patients | Influência dos factores socio-demográficos e clínicos na qualidade de vida relacionada com a saúde dos doentes hemato-oncológicos". Arquivos de Medicina 24 3 (2010): 79-87. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857461852&partnerID=MN8TOARS.
  45. Braga, P.; Carvalho, S.; Gomes, M.; Guerra, L.; Paulo, L.; Marques, H.; Negreiro, F.; et al. "Economic analysis of rituximab: In combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in portugal | Análise económica de rituximab: Em associação com ciclofosfamida, vincristina e prednisolona no tratamento de doentes com linfoma folicular avançado em portugal". Acta Medica Portuguesa 23 6 (2010): 1025-1034. http://www.scopus.com/inward/record.url?eid=2-s2.0-78751488553&partnerID=MN8TOARS.
  46. Braga P; Carvalho S; Gomes M; Guerra L; Lúcio P; Marques H; Negreiro F; et al. "[Economic analysis of rituximab in combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in Portugal].". (2010): http://europepmc.org/abstract/med/21627880.
  47. Ventura F; Pereira T; da Luz Duarte M; Marques H; Pardal F; Brito C. "Indeterminate cell histiocytosis in association with acute myeloid leukemia.". (2010): http://europepmc.org/abstract/med/20672000.
    10.1155/2010/569345
  48. Queiroz,Luísa; Sousa,Filipa; Marques,Herlander. "Influência dos Factores Socio-Demográficos e Clínicos na Qualidade de Vida Relacionada com a Saúde dos Doentes Hemato-Oncológicos". (2010): http://scielo.pt/scielo.php?script=sci_arttext&pid=S0871-34132010000300001.
  49. Braga, Paula; Carvalho, Susana; Gomes, Marília; Guerra, Lurdes; Lúcio, Paulo; Marques, Herlander; Negreiro, Filipa; et al. "Economic analysis of rituximab in combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in Portugal.". (2010): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/746.
    10.20344/amp.746
  50. Ventura, F.; Rocha, J.; Pereira, T.; Marques, H.; Pardal, F.; Brito, C.. "Sweet syndrome as the presenting symptom of hairy cell leukemia". Dermatology Online Journal 15 2 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-61849113343&partnerID=MN8TOARS.
  51. Almeida, A.; Castro, I.; Coutinho, J.; Guerra, L.; Marques, H.; Pereira, A.M.. "Recommendations for diagnosis, treatment and monitoring of chronic myeloid leukemia | Recomendações para o diagnóstico, tratamento e monitorização da leucemia mielóide crónica". Acta Medica Portuguesa 22 5 (2009): 537-544. http://www.scopus.com/inward/record.url?eid=2-s2.0-77149124911&partnerID=MN8TOARS.
  52. Almeida, António; Castro, Isabel; Coutinho, Jorge; Guerra, Lurdes; Marques, Herlander; Pereira, Ana Marques. "Recommendations for diagnosis, treatment and monitoring of chronic myeloid leukemia.". (2009): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1720.
    10.20344/amp.1720
  53. Paiva, M.; Marques, H.; Martins, A.; Ferreira, P.; Catarino, R.; Medeiros, R.. "Fc¿RIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients". Cancer Genetics and Cytogenetics 183 1 (2008): 35-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-43149113005&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2008.02.001
  54. Mata-Lima,Herlander; Vargas,Hugo; Carvalho,Julia; Gonçalves,Marcia; Caetano,Hugo; Marques,Andreia; Raminhos,Cristina. "Comportamento hidrológico de bacias hidrográficas: integração de métodos e aplicação a um estudo de caso". (2007): http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0370-44672007000300014.
  55. Furones, M.; Marques, H.; Viterbo, L.; Marìz, M.; Coutinho, C.; Costa, N.; Viseu, F.. "Irinotecan (CPT-11) in resistant non-Hodgkin's lymphoma | Ironetecano (CPT-11) no linfoma não-Hodgkin resistente". Arquivos de Medicina 18 4 (2004): http://www.scopus.com/inward/record.url?eid=2-s2.0-17444391272&partnerID=MN8TOARS.
  56. Afonso, N.; Marques, H.; Marques, M.; Viterbo, L.; Mariz, M.; Correia, C.; Gomes, P.; Viseu, F.. "Acute leukemias secondary to breast cancer treatment | Leucemias secundárias ao tratamento de carcinoma da mama". Arquivos de Medicina 15 4-6 (2001): 99-103. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035564443&partnerID=MN8TOARS.
  57. Marques, H.; Ferreira, E.; Oliveira, A.; Proença, G.; Marques, M.; Teixeira, P.; Vieira, E.; Viseu, F.. "Primary lymphomas of the brain not related to immunodeficiency | Linfomas primários do cérebro não ligados à imunodeficiência.". Acta medica portuguesa 8 3 (1995): 151-156. http://www.scopus.com/inward/record.url?eid=2-s2.0-17644438669&partnerID=MN8TOARS.
Tese / Dissertação
  1. Dias, Hugo André Marques. "Flat Design Branding". Mestrado, 2015. http://hdl.handle.net/10400.6/6513.
  2. Marques, Herlander. "Vírus herpes-¿ e polimorfismos dos sistemas de processamento antigénico : importância na oncogénese e no prognóstico dos linfomas de células B". Doutoramento, 2014. http://hdl.handle.net/1822/34475.

Outros

Outra produção
  1. Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. [Excerpt] In this Article, members of the UCSF cohort who had been alive for longer than two years were inadvertently included in the data presented in Table 3. USCF/old treatments should have 109 patients with a hazard ratio of 3.35 and a P value of 0.00028 instead of the 124 patients with a hazard ratio of 3.37 and a P value of 0.00026. The USCF/new patients should have 187 patients with a hazar. 2015. Ziv, Elad; Dean, Eric; Hu, Donglei; Martino, Alessandro; Serie, Daniel; Curtin, Karen; Campa, Daniele; et al. http://hdl.handle.net/1822/62281.
    10.1038/ncomms10203
  2. Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. 2012. Reis, R. M.; Martino, Alessandro; Campa, Daniele; Jamroziak, Krzysztof; Sainz, Juan; Buda, Gabriele; García-Sanz, Ramón; et al. http://hdl.handle.net/1822/33624.
    10.1111/j.1365-2141.2012.09244.x